291 related articles for article (PubMed ID: 29317535)
21. A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.
Kraus TA; Lau JF; Parisien JP; Horvath CM
J Biol Chem; 2003 Apr; 278(15):13033-8. PubMed ID: 12574168
[TBL] [Abstract][Full Text] [Related]
22. IFN-beta-mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9.
Laver T; Nozell SE; Benveniste EN
J Interferon Cytokine Res; 2008 Jan; 28(1):13-23. PubMed ID: 18370868
[TBL] [Abstract][Full Text] [Related]
23. Porcine bocavirus NP1 negatively regulates interferon signaling pathway by targeting the DNA-binding domain of IRF9.
Zhang R; Fang L; Wang D; Cai K; Zhang H; Xie L; Li Y; Chen H; Xiao S
Virology; 2015 Nov; 485():414-21. PubMed ID: 26342467
[TBL] [Abstract][Full Text] [Related]
24. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
[TBL] [Abstract][Full Text] [Related]
25. Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9.
Zurney J; Kobayashi T; Holm GH; Dermody TS; Sherry B
J Virol; 2009 Mar; 83(5):2178-87. PubMed ID: 19109390
[TBL] [Abstract][Full Text] [Related]
26. Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.
Sung PS; Cheon H; Cho CH; Hong SH; Park DY; Seo HI; Park SH; Yoon SK; Stark GR; Shin EC
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10443-8. PubMed ID: 26216956
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of interferon regulatory factor 9 (IRF9).
Paul A; Ismail MN; Tang TH; Ng SK
Mol Biol Rep; 2023 Apr; 50(4):3909-3917. PubMed ID: 36662450
[TBL] [Abstract][Full Text] [Related]
28. IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
Cheon H; Holvey-Bates EG; Schoggins JW; Forster S; Hertzog P; Imanaka N; Rice CM; Jackson MW; Junk DJ; Stark GR
EMBO J; 2013 Oct; 32(20):2751-63. PubMed ID: 24065129
[TBL] [Abstract][Full Text] [Related]
29. Role of metazoan mediator proteins in interferon-responsive transcription.
Lau JF; Nusinzon I; Burakov D; Freedman LP; Horvath CM
Mol Cell Biol; 2003 Jan; 23(2):620-8. PubMed ID: 12509459
[TBL] [Abstract][Full Text] [Related]
30. [ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV].
Zhang Q; Wei L; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):110-3. PubMed ID: 16027772
[TBL] [Abstract][Full Text] [Related]
31. Acetylation-dependent signal transduction for type I interferon receptor.
Tang X; Gao JS; Guan YJ; McLane KE; Yuan ZL; Ramratnam B; Chin YE
Cell; 2007 Oct; 131(1):93-105. PubMed ID: 17923090
[TBL] [Abstract][Full Text] [Related]
32. Porcine Reproductive and Respiratory Syndrome Virus nsp11 Antagonizes Type I Interferon Signaling by Targeting IRF9.
Wang D; Chen J; Yu C; Zhu X; Xu S; Fang L; Xiao S
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092569
[TBL] [Abstract][Full Text] [Related]
33. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3.
Martinez-Moczygemba M; Gutch MJ; French DL; Reich NC
J Biol Chem; 1997 Aug; 272(32):20070-6. PubMed ID: 9242679
[TBL] [Abstract][Full Text] [Related]
34. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency.
Gothe F; Stremenova Spegarova J; Hatton CF; Griffin H; Sargent T; Cowley SA; James W; Roppelt A; Shcherbina A; Hauck F; Reyburn HT; Duncan CJA; Hambleton S
J Allergy Clin Immunol; 2022 Oct; 150(4):955-964.e16. PubMed ID: 35182547
[TBL] [Abstract][Full Text] [Related]
35. Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms.
Verweij MC; Wellish M; Whitmer T; Malouli D; Lapel M; Jonjić S; Haas JG; DeFilippis VR; Mahalingam R; Früh K
PLoS Pathog; 2015 May; 11(5):e1004901. PubMed ID: 25973608
[TBL] [Abstract][Full Text] [Related]
36. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.
Tsuno T; Mejido J; Zhao T; Schmeisser H; Morrow A; Zoon KC
J Immunother; 2009 Oct; 32(8):803-16. PubMed ID: 19752753
[TBL] [Abstract][Full Text] [Related]
37. Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling.
Maiwald T; Schneider A; Busch H; Sahle S; Gretz N; Weiss TS; Kummer U; Klingmüller U
FEBS J; 2010 Nov; 277(22):4741-54. PubMed ID: 20964804
[TBL] [Abstract][Full Text] [Related]
38. IRF9-Stat2 Fusion Protein as an Innate Immune Inducer to Activate Mx and Interferon-Stimulated Gene Expression in Zebrafish Larvae.
Huang CJ; Chou CM; Lien HW; Chu CY; Ho JY; Wu Y; Cheng CH
Mar Biotechnol (NY); 2017 Jun; 19(3):310-319. PubMed ID: 28500614
[TBL] [Abstract][Full Text] [Related]
39. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1.
Lou YJ; Pan XR; Jia PM; Li D; Xiao S; Zhang ZL; Chen SJ; Chen Z; Tong JH
Cancer Res; 2009 Apr; 69(8):3673-80. PubMed ID: 19351818
[TBL] [Abstract][Full Text] [Related]
40. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
Zhang L; Jilg N; Shao RX; Lin W; Fusco DN; Zhao H; Goto K; Peng LF; Chen WC; Chung RT
J Hepatol; 2011 Aug; 55(2):289-98. PubMed ID: 21147189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
